Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 460.18 Million USD | -0.42% |
| 2021 | 462.13 Million USD | 28.54% |
| 2020 | 359.53 Million USD | 6.46% |
| 2019 | 337.72 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 490.72 Million USD | 11.09% |
| 2023 Q1 | 441.71 Million USD | -4.01% |
| 2023 Q3 | 498.55 Million USD | 1.6% |
| 2022 FY | 460.18 Million USD | -0.42% |
| 2022 Q1 | 483.27 Million USD | 4.57% |
| 2022 Q4 | 460.18 Million USD | -2.33% |
| 2022 Q2 | 470.19 Million USD | -2.71% |
| 2022 Q3 | 471.17 Million USD | 0.21% |
| 2021 Q1 | 335.19 Million USD | -6.77% |
| 2021 FY | 462.13 Million USD | 28.54% |
| 2021 Q4 | 462.13 Million USD | -0.56% |
| 2021 Q3 | 464.74 Million USD | 32.02% |
| 2021 Q2 | 352.03 Million USD | 5.02% |
| 2020 Q4 | 359.53 Million USD | 0.0% |
| 2020 FY | 359.53 Million USD | 6.46% |
| 2019 FY | 337.72 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -594.144% |
| Safety Shot Inc | 12.7 Million USD | -3520.902% |
| Bright Green Corporation | 17.4 Million USD | -2544.29% |
| Embecta Corp. | 1.21 Billion USD | 62.106% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 49.118% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -701.468% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 59.75% |
| Dynavax Technologies Corporation | 997.09 Million USD | 53.847% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -123.613% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 36.813% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 70.77% |
| PainReform Ltd. | 9.93 Million USD | -4534.31% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -1582.772% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -1582.772% |
| SCYNEXIS, Inc. | 128.41 Million USD | -258.368% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -1889.821% |
| Journey Medical Corporation | 76.84 Million USD | -498.82% |
| Alpha Teknova, Inc. | 128.58 Million USD | -257.88% |
| Theratechnologies Inc. | 77.76 Million USD | -491.736% |
| Harrow Health, Inc. | 311.75 Million USD | -47.612% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -2989.955% |
| Biofrontera Inc. | 27.93 Million USD | -1547.526% |
| DURECT Corporation | 45.18 Million USD | -918.361% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 67.339% |
| Cronos Group Inc. | 1.13 Billion USD | 59.428% |
| OptiNose, Inc. | 107.72 Million USD | -327.171% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 2.311% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -722.512% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -1896.721% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -0.035% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -3761.22% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -462.74% |
| Radius Health, Inc. | 1.71 Billion USD | 73.182% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -763.6% |
| ProPhase Labs, Inc. | 91.92 Million USD | -400.6% |
| Phibro Animal Health Corporation | 982.18 Million USD | 53.147% |
| Procaps Group S.A. | 460.18 Million USD | 0.0% |
| Alvotech | 950.09 Million USD | 51.564% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -962.567% |
| Viatris Inc. | 47.68 Billion USD | 99.035% |
| Rockwell Medical, Inc. | 52.17 Million USD | -782.041% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -289.675% |
| SIGA Technologies, Inc. | 254.83 Million USD | -80.581% |
| Tilray Brands, Inc. | 4.33 Billion USD | 89.385% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -68.134% |
| Shineco, Inc. | 84.17 Million USD | -446.674% |
| PetIQ, Inc. | 868.22 Million USD | 46.997% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -5353.609% |
| Incannex Healthcare Limited | 17.04 Million USD | -2599.519% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 85.846% |
| Alimera Sciences, Inc. | 153.52 Million USD | -199.749% |
| Silver Spike Investment Corp. | 88.57 Million USD | -419.538% |
| Assertio Holdings, Inc. | 286.41 Million USD | -60.669% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -7631.979% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -1261.669% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -1372.928% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -3373.755% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -76.232% |
| Hempacco Co., Inc. | 18.04 Million USD | -2450.49% |
| Talphera, Inc. | 20.39 Million USD | -2156.372% |
| Alvotech | 950.09 Million USD | 51.564% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -13.302% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 72.129% |
| Currenc Group, Inc. | 141.49 Million USD | -225.242% |
| Kamada Ltd. | 351.96 Million USD | -30.746% |
| Indivior PLC | 1.95 Billion USD | 76.416% |
| Evoke Pharma, Inc. | 7.06 Million USD | -6410.349% |
| Flora Growth Corp. | 23.62 Million USD | -1847.799% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -3373.755% |
| Evolus, Inc. | 188.99 Million USD | -143.488% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 64.042% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 69.583% |
| Akanda Corp. | 8.83 Million USD | -5105.739% |